PCSK9 is highly conserved across species. So it's a heavily de-risk target and something that the non-human primate models which we had very positive data in. Our Alzheimer's vaccine has gone through four separate Cuban trials. And we generate very similar antibodies to a drug that's been in the press a lot recently, Lucanamab. We're actually doing that the first trial in in Australia.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode